Anti-ARRDC3 antibody
- BOND RX™ Validated
- What is this?
Be the first to review this product! Submit a review
|
(13 Publications)
Rabbit Polyclonal ARRDC3 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human, Rat, Mouse samples. Cited in 13 publications. Immunogen corresponding to Synthetic Peptide within Human ARRDC3.
View Alternative Names
KIAA1376, ARRDC3, Arrestin domain-containing protein 3, TBP-2-like inducible membrane protein, TLIMP
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ARRDC3 antibody (AB64817)
IHC image of ab64817 staining in normal human hippocampus formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab64817, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-ARRDC3 antibody (AB64817)
ICC/IF image of ab64817 stained PC12 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab64817, 5µg/ml) overnight at +4°C. The secondary antibody (green) was ab96899, DyLight® 488 goat anti-rabbit IgG (H+L) used at a 1/250 dilution for 1h.Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
- WB
Unknown
Western blot - Anti-ARRDC3 antibody (AB64817)
All lanes:
Western blot - Anti-ARRDC3 antibody (ab64817) at 1/500 dilution
Lane 1:
Extracts from Jurkat cells at 5 µg
Lane 2:
Extracts from COLO205 cells at 5 µg
Lane 3:
Extracts from COLO205 cells at 5 µg with immunising peptide
Predicted band size: 46 kDa
Observed band size: 46 kDa
false
- WB
Unknown
Western blot - Anti-ARRDC3 antibody (AB64817)
All lanes:
Western blot - Anti-ARRDC3 antibody (ab64817) at 1/500 dilution
Lane 1:
Rat brain lysates
Lane 2:
Mouse brain lysates
Lane 3:
Mouse brain lysates with immunizing peptide
Predicted band size: 46 kDa
Observed band size: 46 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ARRDC3 influences cellular communication and adapts cellular responses. As part of a complex that includes members of the NEDD4 family E3 ligases it influences ubiquitination processes. ARRDC3 modulates the degradation and downregulation of G-protein-coupled receptors (GPCRs) which plays an important role in maintaining cellular signaling dynamics. This regulation affects multiple cellular functions including receptor recycling and signal transduction efficiency.
Pathways
ARRDC3 prominently integrates into the ubiquitin-proteasome system and GPCR signaling pathways. It functions in pathways that manage receptor trafficking and desensitization. The protein interacts closely with β-arrestins which play significant roles in GPCR internalization. The coordination with these proteins ensures the proper signaling cascade and termination impacting overall pathway efficiency.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (13)
Recent publications for all applications. Explore the full list and refine your search
Cell cycle (Georgetown, Tex.) 23:56-69 PubMed38389126
2024
Applications
Unspecified application
Species
Unspecified reactive species
Head and neck pathology 17:658-672 PubMed37486532
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular reproduction and development 90:406-416 PubMed37436094
2023
Applications
Unspecified application
Species
Unspecified reactive species
Open medicine (Warsaw, Poland) 18:20220546 PubMed37215052
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 10: PubMed30545011
2018
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 8:52935-52947 PubMed28881784
2017
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 291:14510-25 PubMed27226565
2016
Applications
Unspecified application
Species
Human
BMC genomics 15:644 PubMed25086961
2014
Applications
WB, IP
Species
Mouse, Mouse
Scientific reports 4:3846 PubMed24457910
2014
Applications
WB
Species
Human
Journal of cell science 126:4457-68 PubMed23886940
2013
Applications
WB
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com